Over time, the prevalence of chronic diseases has risen, attributed to an increasingly sedentary lifestyle. Moreover, rising demand for biotechnology tools in agricultural applications and increasing demand for genetics and regenerative medicine bolster the biotech industry.
Given the industry’s bright prospects, it could be wise to invest in fundamentally strong biotech stocks, such as BioMarin Pharmaceutical Inc. (BMRN), Alnylam Pharmaceuticals, Inc. (ALNY), and Corcept Therapeutics Incorporated (CORT), which have sky-high price targets.
